U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
159421159421Quantitative and Qualitative Changes in Neural Efferent ReceptorsWithdrawnNo Results AvailableSpinal Cord Injury|Bladder Dysfunctionhttps://ClinicalTrials.gov/show/NCT00472784
159422159422INNO-206 in Patients With Small Cell Lung Cancer (SCLC)WithdrawnNo Results AvailableSmall Cell Lung CancerDrug: INNO-206https://ClinicalTrials.gov/show/NCT00472771
159423159423A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545CompletedNo Results AvailableChronic Plaque PsoriasisBiological: MEDI 545|Other: Placebohttps://ClinicalTrials.gov/show/NCT00472758
159424159424The Effect of Weight Loss on Bone in MenCompletedNo Results AvailableWeight Loss|BMDBehavioral: Weight Loss|Behavioral: Weight Maintenancehttps://ClinicalTrials.gov/show/NCT00472745
159425159425Neurologic Injuries in Adults With Urea Cycle DisordersCompletedHas ResultsBrain Diseases, Metabolic, Inborn|Urea Cycle Disorder|Ornithine Transcarbamylase Deficiencyhttps://ClinicalTrials.gov/show/NCT00472732
159426159426Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy AdultsCompletedNo Results AvailableHIV InfectionsBiological: VRC-HIVADV027-00-VP|Biological: VRC-HIVADV038-00-VP|Biological: VRC-HIVDNA044-00-VPhttps://ClinicalTrials.gov/show/NCT00472719
159427159427Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's DiseaseTerminatedNo Results AvailableBowen's DiseaseProcedure: excision|Procedure: Photodynamic therapyhttps://ClinicalTrials.gov/show/NCT00472706
159428159428Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: Bevacizumab, Abraxanehttps://ClinicalTrials.gov/show/NCT00472693
159429159429The Effect of Severe Weight Loss and Protein Intake on BoneRecruitingNo Results AvailableWeight Loss|Dietary ProteinBehavioral: Caloric restriction, high protein|Behavioral: Caloric restriction; normal protein|Behavioral: Nutrition Educationhttps://ClinicalTrials.gov/show/NCT00472680
159430159430PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)CompletedNo Results AvailableBacterial InfectionsProcedure: Procalcitonin guided strategyhttps://ClinicalTrials.gov/show/NCT00472667
159431159431The Effect of Vitamin D Supplementation During Caloric Restriction on Intestinal Calcium AbsorptionCompletedNo Results AvailableWeight Loss|Vitamin D or PlaceboBehavioral: Weight Loss|Dietary Supplement: Vitamin D 2500 IU|Behavioral: Weight Maintenancehttps://ClinicalTrials.gov/show/NCT00472654
159432159432Geodon in Weight Loss Study for Bipolar DisordersCompletedNo Results AvailableBipolar DisorderDrug: Ziprasidone/Geodonhttps://ClinicalTrials.gov/show/NCT00472641
159433159433Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)WithdrawnNo Results AvailableSepsisProcedure: Blood samples collectedhttps://ClinicalTrials.gov/show/NCT00472628
159434159434Menstrual Effects On Mood Symptoms in Bipolar DisorderCompletedNo Results AvailableBipolar Disorderhttps://ClinicalTrials.gov/show/NCT00472615
159435159435Pathogenesis of Liver Fluke Induced Cancer in ThailandRecruitingNo Results AvailableOpisthorchis Viverrinihttps://ClinicalTrials.gov/show/NCT00472602
159436159436A Biological Sample Collection Protocol of Women With and Without Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00472589
159437159437Antidepressant Effects of NR2B in Major DepressionCompletedHas ResultsMajor DepressionDrug: MK-0657|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00472576
159438159438Prevention of Contrast Induced Nephropathy With Sodium BicarbonateCompletedNo Results AvailableAcute Kidney FailureDrug: Bicarbinate 150 mEq/Lhttps://ClinicalTrials.gov/show/NCT00472563
159439159439Esomeprazole and Gastric Emptying of BeerCompletedNo Results AvailableGastroesophageal Reflux|HeartburnDrug: esomeprazole 20 mghttps://ClinicalTrials.gov/show/NCT00472550
159440159440ProLOVE - Prospective Randomized Study of Midline Incisional Hernia TreatmentCompletedNo Results AvailableHERNIA, VENTRALProcedure: Retromuscular Mesh repair of midline incisional hernia|Procedure: Laparoscopic repair of midline incisional herniahttps://ClinicalTrials.gov/show/NCT00472537
159441159441Cycloplegic Delivery InvestigationCompletedNo Results AvailableHealthyProcedure: Mydriasis/cycloplegia via different modes of administrationhttps://ClinicalTrials.gov/show/NCT00472524
159442159442Study of Eyes and Attention Deficit (SEAD)CompletedNo Results AvailableADHD|Convergence Insufficiency|Accommodative Insufficiencyhttps://ClinicalTrials.gov/show/NCT00472511
159443159443Comparison on the Efficacy of a MonophasicTerminatedNo Results AvailableCardiac Arresthttps://ClinicalTrials.gov/show/NCT00472498
159444159444Study of Eye Movement Testing and TherapyCompletedNo Results AvailableSaccadic Eye Movement Deficiency|Oculomotor Deficiency|Oculomotor DysfunctionProcedure: eye movement therapyhttps://ClinicalTrials.gov/show/NCT00472485
159445159445Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal ArteriesCompletedNo Results AvailablePeripheral Arterial DiseaseDevice: paclitaxel coated balloon catheter (device with drug)https://ClinicalTrials.gov/show/NCT00472472
159446159446PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin CancerCompletedNo Results AvailableActinic Keratosis|Warts|Basal Cell Carcinoma|Bowens Disease|Squamous Cell CarcinomaProcedure: Photodynamic therapy with Metvix 160 mg/g creamhttps://ClinicalTrials.gov/show/NCT00472459
159447159447Cervical Block in Thyroid SurgeryCompletedNo Results AvailableThyroidectomyProcedure: superficial cervical blockhttps://ClinicalTrials.gov/show/NCT00472446
159448159448The Efficacy and Safety of Alemtuzumab in Auotoimmune CytopeniasTerminatedNo Results AvailableAutoimmune CytopeniasDrug: Alemtuzumabhttps://ClinicalTrials.gov/show/NCT00472433
159449159449A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.CompletedHas ResultsMantle Cell LymphomaDrug: rituximab [MabThera/Rituxan]|Drug: First line chemotherapyhttps://ClinicalTrials.gov/show/NCT00472420
159450159450Eye Teaming Evaluation StudyCompletedNo Results AvailableConvergence InsufficiencyDevice: NPC targetshttps://ClinicalTrials.gov/show/NCT00472407

* Görseller ve İçerik tekif hakkına sahip olabilir